Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 6 | 2020 | 363 | 2.140 |
Why?
|
| Chronic Disease | 3 | 2021 | 469 | 1.390 |
Why?
|
| Mental Health | 5 | 2023 | 270 | 1.290 |
Why?
|
| Telemedicine | 2 | 2020 | 163 | 1.160 |
Why?
|
| Adult | 19 | 2023 | 11034 | 0.930 |
Why?
|
| Information Seeking Behavior | 2 | 2020 | 23 | 0.920 |
Why?
|
| Health Behavior | 3 | 2021 | 491 | 0.880 |
Why?
|
| Poverty | 2 | 2016 | 316 | 0.870 |
Why?
|
| Residence Characteristics | 2 | 2016 | 301 | 0.850 |
Why?
|
| Humans | 37 | 2023 | 34853 | 0.840 |
Why?
|
| Female | 25 | 2023 | 19873 | 0.830 |
Why?
|
| United States | 15 | 2023 | 3894 | 0.820 |
Why?
|
| Cardiovascular Diseases | 3 | 2023 | 628 | 0.820 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 21 | 0.800 |
Why?
|
| Hypersensitivity | 1 | 2021 | 28 | 0.790 |
Why?
|
| Health Surveys | 2 | 2020 | 358 | 0.780 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 31 | 0.780 |
Why?
|
| Electronic Health Records | 1 | 2021 | 65 | 0.770 |
Why?
|
| Health Care Surveys | 1 | 2020 | 136 | 0.760 |
Why?
|
| Consumer Health Information | 1 | 2020 | 22 | 0.750 |
Why?
|
| Young Adult | 12 | 2021 | 4012 | 0.690 |
Why?
|
| Internet | 1 | 2020 | 204 | 0.680 |
Why?
|
| Middle Aged | 17 | 2021 | 9642 | 0.680 |
Why?
|
| Male | 20 | 2023 | 18870 | 0.660 |
Why?
|
| Adolescent | 12 | 2021 | 5035 | 0.660 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2017 | 25 | 0.620 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 413 | 0.620 |
Why?
|
| Mental Disorders | 1 | 2021 | 285 | 0.620 |
Why?
|
| Career Mobility | 1 | 2017 | 24 | 0.620 |
Why?
|
| Early Detection of Cancer | 2 | 2022 | 292 | 0.600 |
Why?
|
| Employment | 1 | 2017 | 73 | 0.600 |
Why?
|
| Public Housing | 1 | 2016 | 15 | 0.570 |
Why?
|
| Cross-Sectional Studies | 6 | 2023 | 2561 | 0.550 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 531 | 0.500 |
Why?
|
| Neoplasms | 2 | 2022 | 1033 | 0.500 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 790 | 0.490 |
Why?
|
| Allergens | 1 | 2014 | 58 | 0.490 |
Why?
|
| Air Pollution, Indoor | 1 | 2014 | 40 | 0.490 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 1426 | 0.480 |
Why?
|
| Safety | 1 | 2014 | 48 | 0.470 |
Why?
|
| Social Perception | 1 | 2014 | 59 | 0.470 |
Why?
|
| Air Pollutants | 1 | 2014 | 90 | 0.470 |
Why?
|
| Health Promotion | 1 | 2019 | 588 | 0.450 |
Why?
|
| Urban Population | 1 | 2014 | 318 | 0.430 |
Why?
|
| Food Supply | 2 | 2023 | 99 | 0.410 |
Why?
|
| Pleural Neoplasms | 3 | 2015 | 51 | 0.380 |
Why?
|
| Cannabis | 2 | 2022 | 75 | 0.380 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 794 | 0.380 |
Why?
|
| Diet | 1 | 2016 | 747 | 0.360 |
Why?
|
| Los Angeles | 3 | 2015 | 368 | 0.350 |
Why?
|
| Mesothelioma | 3 | 2015 | 135 | 0.350 |
Why?
|
| Students, Medical | 2 | 2021 | 121 | 0.340 |
Why?
|
| Health Status Disparities | 2 | 2016 | 583 | 0.310 |
Why?
|
| New York City | 2 | 2019 | 212 | 0.310 |
Why?
|
| Socioeconomic Factors | 3 | 2017 | 1003 | 0.310 |
Why?
|
| Schools | 1 | 2009 | 229 | 0.300 |
Why?
|
| Environmental Exposure | 1 | 2009 | 207 | 0.290 |
Why?
|
| Combined Modality Therapy | 3 | 2015 | 142 | 0.290 |
Why?
|
| Demography | 2 | 2019 | 167 | 0.290 |
Why?
|
| Prevalence | 3 | 2021 | 1425 | 0.270 |
Why?
|
| Receptors, Progesterone | 2 | 2015 | 78 | 0.250 |
Why?
|
| Receptors, Estrogen | 2 | 2015 | 145 | 0.240 |
Why?
|
| Heart Transplantation | 1 | 2022 | 43 | 0.220 |
Why?
|
| Physicians, Women | 1 | 2022 | 4 | 0.220 |
Why?
|
| Medicine | 1 | 2022 | 31 | 0.210 |
Why?
|
| Risk Factors | 3 | 2021 | 3414 | 0.210 |
Why?
|
| Schools, Medical | 2 | 2021 | 192 | 0.210 |
Why?
|
| Hepacivirus | 1 | 2021 | 59 | 0.200 |
Why?
|
| Poisson Distribution | 1 | 2021 | 39 | 0.200 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 336 | 0.200 |
Why?
|
| Masks | 1 | 2020 | 7 | 0.190 |
Why?
|
| Genetic Heterogeneity | 1 | 2020 | 8 | 0.190 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 35 | 0.190 |
Why?
|
| Environmental Monitoring | 2 | 2014 | 188 | 0.190 |
Why?
|
| Hepatitis C | 1 | 2021 | 120 | 0.190 |
Why?
|
| Health | 1 | 2020 | 28 | 0.190 |
Why?
|
| Aged | 7 | 2021 | 6448 | 0.190 |
Why?
|
| Perception | 1 | 2021 | 183 | 0.180 |
Why?
|
| Communication | 1 | 2021 | 170 | 0.180 |
Why?
|
| Medicaid | 1 | 2021 | 102 | 0.180 |
Why?
|
| Education, Medical | 1 | 2021 | 97 | 0.180 |
Why?
|
| Faculty | 1 | 2020 | 82 | 0.180 |
Why?
|
| Heart Failure | 1 | 2022 | 230 | 0.180 |
Why?
|
| Medicare | 1 | 2021 | 188 | 0.180 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2020 | 75 | 0.180 |
Why?
|
| Patient Compliance | 1 | 2021 | 202 | 0.180 |
Why?
|
| Bankruptcy | 1 | 2019 | 1 | 0.180 |
Why?
|
| Ownership | 1 | 2019 | 10 | 0.170 |
Why?
|
| Trust | 1 | 2020 | 119 | 0.170 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 73 | 0.170 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 570 | 0.170 |
Why?
|
| Housing | 1 | 2019 | 54 | 0.170 |
Why?
|
| Survivors | 1 | 2019 | 126 | 0.160 |
Why?
|
| Rescue Work | 1 | 2017 | 5 | 0.160 |
Why?
|
| Occupations | 1 | 2017 | 20 | 0.160 |
Why?
|
| Age Factors | 3 | 2015 | 1007 | 0.150 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 213 | 0.150 |
Why?
|
| Survival Analysis | 2 | 2016 | 322 | 0.150 |
Why?
|
| Child | 2 | 2015 | 2875 | 0.150 |
Why?
|
| Puerto Rico | 1 | 2021 | 1352 | 0.140 |
Why?
|
| Sweetening Agents | 1 | 2016 | 12 | 0.140 |
Why?
|
| Esophagectomy | 1 | 2016 | 6 | 0.140 |
Why?
|
| Beverages | 1 | 2016 | 64 | 0.140 |
Why?
|
| Trinidad and Tobago | 1 | 2015 | 2 | 0.140 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2015 | 2 | 0.140 |
Why?
|
| Delayed Diagnosis | 1 | 2015 | 28 | 0.130 |
Why?
|
| Vegetables | 1 | 2016 | 135 | 0.130 |
Why?
|
| Cockroaches | 1 | 2014 | 5 | 0.130 |
Why?
|
| Fruit | 1 | 2016 | 159 | 0.130 |
Why?
|
| Incidence | 1 | 2017 | 882 | 0.130 |
Why?
|
| Mastectomy | 1 | 2014 | 19 | 0.130 |
Why?
|
| Esophageal Neoplasms | 1 | 2016 | 124 | 0.130 |
Why?
|
| New York | 1 | 2014 | 69 | 0.130 |
Why?
|
| Carcinoma | 1 | 2015 | 94 | 0.120 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2014 | 45 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 176 | 0.120 |
Why?
|
| Multilevel Analysis | 1 | 2014 | 16 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2014 | 116 | 0.120 |
Why?
|
| Psychology | 1 | 2014 | 32 | 0.120 |
Why?
|
| Neutrophils | 1 | 2014 | 124 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 239 | 0.120 |
Why?
|
| Women's Health | 1 | 2014 | 135 | 0.120 |
Why?
|
| Fungi | 1 | 2014 | 86 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2017 | 1422 | 0.120 |
Why?
|
| Registries | 1 | 2015 | 330 | 0.120 |
Why?
|
| Family Characteristics | 1 | 2014 | 102 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2014 | 517 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2014 | 210 | 0.110 |
Why?
|
| Regression Analysis | 1 | 2014 | 429 | 0.110 |
Why?
|
| Child, Preschool | 1 | 2015 | 1318 | 0.100 |
Why?
|
| Inflammation | 1 | 2014 | 577 | 0.090 |
Why?
|
| Minority Groups | 1 | 2014 | 537 | 0.090 |
Why?
|
| Boston | 1 | 2009 | 20 | 0.090 |
Why?
|
| Qualitative Research | 2 | 2022 | 393 | 0.080 |
Why?
|
| Occupational Exposure | 1 | 2009 | 67 | 0.080 |
Why?
|
| Sex Factors | 3 | 2015 | 859 | 0.080 |
Why?
|
| Rats | 1 | 2014 | 3261 | 0.070 |
Why?
|
| SEER Program | 2 | 2016 | 87 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 2333 | 0.070 |
Why?
|
| Survival Rate | 2 | 2015 | 310 | 0.060 |
Why?
|
| American Heart Association | 1 | 2023 | 17 | 0.060 |
Why?
|
| Mice | 1 | 2014 | 5668 | 0.060 |
Why?
|
| Masculinity | 1 | 2022 | 15 | 0.050 |
Why?
|
| Intention | 1 | 2022 | 84 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 254 | 0.050 |
Why?
|
| Problem-Based Learning | 1 | 2021 | 32 | 0.050 |
Why?
|
| Prejudice | 1 | 2021 | 101 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2019 | 36 | 0.040 |
Why?
|
| Cities | 1 | 2019 | 61 | 0.040 |
Why?
|
| Animals | 1 | 2014 | 14307 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1056 | 0.040 |
Why?
|
| Cognition | 1 | 2019 | 373 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 269 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2014 | 46 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1353 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 423 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 707 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 964 | 0.030 |
Why?
|
| Smoking | 1 | 2019 | 903 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2016 | 1349 | 0.030 |
Why?
|
| Hypertension | 1 | 2019 | 770 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 446 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2016 | 1961 | 0.020 |
Why?
|
Camacho-Rivera's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_